Principal ScientistVega Therapeutics, South San FranciscoSouth San Francisco, California, United States
PB1110 - VGA039, a novel anti-Protein S antibody, enhances ex vivo coagulation with hemophilia A blood as assessed by thromboelastometry
Tuesday, June 25, 202413:45 – 14:45 ICT